Nanotechnology, NanoMedicine and Nanotoxicology Experts To Advise President on Bioethics of Nanomedicine

One of today’s hottest areas of scientific research is nanomedicine. Scientists currently are working to create novel nanostructures that can serve as new kinds of drugs for treating cancer, Parkinson’s, and cardiovascular disease. They also are seeking ways to engineer nanomaterials for use as artificial tissues that could replace diseased kidneys and livers, and even repair nerve damage.

In addition, although the research is still exploratory, scientists are beginning to build nanostructures that mimic complex biomolecules. Some of these engineered structures appear to have regenerative powers that could potentially lead to therapies for conditions such as Alzheimer’s, nerve injury and brain damage from stroke.

Dr. Andrew Maynard, chief science advisor for the Wilson Center’s Project on Emerging Nanotechnologies, and Dr. Mauro Ferrari, chairman, Department of Biomedical Engineering, University of Texas Health Science Center at Houston, have been invited to discuss nanotechnology and nanomedicine before a meeting of the President’s Council on Bioethics. At a special session on nanotechnology to be held on Friday, June 29th, beginning at 8:30 a.m., they will present the exciting possibilities that these technologies present, as well as potenial risks and ethical implications.

For a full meeting agenda, see: http://www.bioethics.gov/transcripts/june07/juneagenda.html

Meeting press contact is: Diane M. Gianelli, Director of Communications, The President’s Council on Bioethics, (202) 296-4669.

To learn more about nanotechnology, particularly its medical applications, log onto the report NanoFrontiers: Visions for the Future of Nanotechnology at www.nanotechproject.org/119

  • Who:    Dr. Andrew D. Maynard, Chief Science Advisor, Project on Emerging Nanotechnologies & Dr. Mauro Ferrari, Chairman, Department of Biomedical Engineering, University of Texas Health Science Center at Houston
  • What:    President’s Council on Bioethics meeting, session on nanotechnology           
  • When:        Friday, June 29, 2007, 8:30 a.m. - 11:45 a.m
  • Where:    Hay-Adams Hotel, 16th & H Streets, NW, Washington, DC

The Project on Emerging Nanotechnologies was launched in 2005 by the Woodrow Wilson Center and The Pew Charitable Trusts. It is dedicated to helping businesses, governments, and the public anticipate and manage the possible health and environmental implications of nanotechnology.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Project on Emerging Nanotechnologies. (2019, March 19). Nanotechnology, NanoMedicine and Nanotoxicology Experts To Advise President on Bioethics of Nanomedicine. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=4325.

  • MLA

    Project on Emerging Nanotechnologies. "Nanotechnology, NanoMedicine and Nanotoxicology Experts To Advise President on Bioethics of Nanomedicine". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=4325>.

  • Chicago

    Project on Emerging Nanotechnologies. "Nanotechnology, NanoMedicine and Nanotoxicology Experts To Advise President on Bioethics of Nanomedicine". AZoNano. https://www.azonano.com/news.aspx?newsID=4325. (accessed November 21, 2024).

  • Harvard

    Project on Emerging Nanotechnologies. 2019. Nanotechnology, NanoMedicine and Nanotoxicology Experts To Advise President on Bioethics of Nanomedicine. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=4325.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.